JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹27 Cr | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹8.12 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹9.27 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | -4.96 | |
| Mar2025 | ₹28 Cr | 243.50 | |
| Mar2024 | ₹8.12 Cr | -52.36 | |
| Mar2023 | ₹17 Cr | 83.93 | |
| Mar2022 | ₹9.27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹375.8 Cr | -0.7% | -9% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -0.7% |
-9% |
-19.9% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses